6 MIN READ

Apigenin: CD38 Inhibitor, Sleep Support, and NAD+ Protector (2026)

If you take NMN (nicotinamide mononucleotide – the direct precursor your body converts into NAD+) to boost your NAD+ (nicotinamide adenine dinucleotide – a coenzyme required for cellular energy and DNA repair) levels, there is an enzyme in your body actively working to destroy that NAD+ before your cells can use it. It is called CD38 (an enzyme that consumes NAD+ – its activity increases with age) – and its activity increases dramatically with age.

Apigenin inhibits CD38. It also supports sleep through a separate mechanism involving GABA-A receptors. This dual action – protecting NAD+ during the day, promoting restorative sleep at night – makes it one of the most underappreciated compounds in longevity science.

TL;DR – Key Takeaways

  • CD38 is the dominant consumer of NAD+ in aged tissue – it intercepts NMN in transit and destroys NAD+ before cells can use it
  • CD38 expression is driven by senescent cell SASP and chronic inflammation – a direct link between cellular aging and NAD+ depletion
  • Apigenin potently inhibits CD38 at concentrations achievable with oral supplementation (IC50 < 10 μM)
  • Apigenin also modulates GABA-A receptors, supporting sleep onset without dependency risks
  • Taking apigenin in the evening while supplementing NMN in the morning is mechanistically synergistic
  • 50 mg of aglycone apigenin provides the equivalent of ~12–100 cups of chamomile tea

Quick Facts: Apigenin

  • Dose: 50 mg
  • Form: Aglycone (deglycosylated)
  • Timing: Evening, 30-60 min before bed
  • Evidence: Moderate (CD38 inhibition confirmed in mice; sleep data from chamomile RCTs)
  • Who it's for: Anyone supplementing NMN or seeking non-sedative sleep support

The CD38 Problem

NAD+ declines roughly 50% between age 20 and age 50. While reduced biosynthesis plays a role, the dominant cause is increased destruction of NAD+ by CD38 – a glycohydrolase expressed on immune cell surfaces.

The landmark paper establishing this came from the Chini laboratory: Camacho-Pereira et al. demonstrated in Cell Metabolism (2016; PMC4911708) that CD38 expression increases dramatically with aging, and that CD38-knockout mice maintain youthful NAD+ levels well into old age. Critically, CD38 does not just destroy existing NAD+ – it intercepts NMN, the direct precursor to NAD+, before it can be converted. CD38 sabotages NAD+ replacement therapy at the source.

What drives CD38 to increase? Covarrubias et al. (Nature Metabolism, 2020; PMID 33199924) connected the dots: senescent cells (damaged cells that stop dividing but refuse to die – they secrete inflammatory signals that damage surrounding tissue) accumulate → release inflammatory SASP (senescence-associated secretory phenotype – the cocktail of inflammatory signals senescent cells release) → induce CD38-expressing macrophages in tissues → macrophages destroy tissue NAD+. A vicious cycle where aging begets more aging.

This is precisely why clearing senescent cells (via fisetin and quercetin – senolytics, compounds that selectively clear senescent cells) reduces the upstream driver of CD38 expression. For the full senescent cell story, see Fisetin: The Most Potent Natural Senolytic.

How Apigenin Stops CD38

In 2013, Escande and Chini published the definitive finding: apigenin is a potent inhibitor of CD38, at concentrations achievable with oral supplementation (IC50 < 10 μM). In obese mice, apigenin treatment resulted in CD38 inhibition → higher liver NAD+ → improved glucose homeostasis → improved metabolic function (Diabetes, 2013; PMC3609577).

This creates a mechanistic bridge between senolytic and NAD+ compounds. When you take NMN in the morning, it must travel through the bloodstream to reach cells. CD38 on immune cell surfaces intercepts and degrades NMN in transit. By inhibiting CD38 with apigenin (taken in the evening), you protect the NMN from premature degradation, increasing the proportion that successfully reaches cells and becomes NAD+.

This is not merely additive. It is a mechanistically synergistic interaction: boost supply (NMN) and reduce destruction (apigenin) simultaneously. For a full evidence ranking of apigenin, NMN, and other longevity compounds, see the Compound Index.

Key Takeaway: CD38 is the primary reason your NAD+ levels crash with age – and it actively intercepts NMN before it can become NAD+. Apigenin inhibits CD38 at achievable oral doses, making it mechanistically synergistic with NMN supplementation. Take NMN in the morning to boost supply; take apigenin in the evening to reduce destruction.

At a glance: apigenin vs. other sleep-supporting compounds:

Compound Primary Mechanism NAD+ Benefit Dependency Risk Typical Dose Best Timing
Apigenin GABA-A modulation + CD38 inhibition Yes (CD38 inhibition) None known 50 mg Evening
Magnesium L-threonate NMDA receptor modulation No None 144 mg Mg Evening
Melatonin MT1/MT2 receptor agonist No Low (feedback risk) 0.3-1 mg Evening
L-theanine GABA/glutamate modulation No None 200 mg Evening

The Sleep Connection

Apigenin's second mechanism is completely distinct from CD38 inhibition. It is a positive allosteric modulator of GABA-A receptors – the same receptor system targeted by benzodiazepines and sleep medications, but through a different binding site.

GABA is the brain's primary inhibitory neurotransmitter. When activated, GABA-A receptors reduce neuronal excitability, promoting relaxation and sleep onset. Apigenin binds to GABA-A receptors and gently enhances GABA's inhibitory effect – producing a dose-dependent calming action without the dependency risks associated with pharmaceutical GABA modulators (Viola et al., Planta Medica, 1995; PMC4863311). Andrew Huberman takes 50mg apigenin nightly as part of his sleep stack, alongside magnesium L-threonate and L-theanine. He recommends taking it 30-60 minutes before bed. This public endorsement has made apigenin one of the most searched sleep supplements in the biohacking community.

A 2024 review in Frontiers in Nutrition (PMC10929570) synthesized the evidence: dietary apigenin intake positively correlates with sleep quality in a large adult cohort, and the compound sits at the unique intersection of sleep biology and aging biology – supporting both GABA-mediated sleep onset and CD38-mediated NAD+ preservation.

Most human clinical data comes from standardized chamomile extract trials – chamomile being approximately 1–2% apigenin by weight. A 2024 systematic review (PMC11109927) confirmed chamomile extract significantly reduces generalized anxiety symptoms and improves sleep quality across multiple RCTs (randomized controlled trials – the gold standard of clinical evidence). The attribution to apigenin is scientifically reasonable – it is chamomile's primary bioactive flavone with confirmed GABA-A binding – but precision requires noting these are chamomile trials, not isolated apigenin trials.

Key Takeaway: Apigenin modulates GABA-A receptors through a different binding site than benzodiazepines, producing gentle sleep support without dependency risks. Evening dosing at 50mg maximizes this benefit while simultaneously providing overnight CD38 inhibition – addressing two longevity pillars (sleep quality and NAD+ preservation) with a single compound.

The Three-Way Senolytic Mechanism

These three senolytic compounds work on different points of the same cascade:

  1. Fisetin + Quercetin reduce the senescent cell burden that generates CD38-inducing SASP
  2. Apigenin directly inhibits the CD38 that is already present
  3. Apigenin additionally suppresses NF-κB – the transcription factor that drives both SASP production and CD38 gene expression

This is a mechanistically coherent formulation, not a collection of trending ingredients. To see how this connects to the broader aging framework, see The 12 Hallmarks of Aging.

Key Takeaway: Apigenin works at three levels of the senescence-NAD+ cascade: it inhibits existing CD38, suppresses the NF-kB signaling that drives new CD38 expression, and pairs with senolytics like fisetin and quercetin that clear the senescent cells generating CD38-inducing inflammation. This three-pronged approach is mechanistically coherent, not just a stack of trending ingredients.

Safety Note: Apigenin modulates GABA-A receptors, the same system targeted by benzodiazepines and sleep medications. Do not combine apigenin with sedatives, benzodiazepines, or alcohol without medical guidance. Pregnant and breastfeeding women should avoid supplemental apigenin due to insufficient safety data.

Dietary Sources and the Supplementation Gap

Apigenin is widely distributed in plants. Dried parsley contains ~45,000 μg/g – an extraordinary concentration. A cup of chamomile tea provides approximately 0.5–4 mg. To reach 50 mg from chamomile tea alone would require drinking 12–100 cups per day.

Supplemental apigenin at 50 mg in the aglycone form – already deglycosylated – bypasses the hydrolysis requirement that limits absorption from food sources. Evening dosing maximizes the GABA-A sleep support benefit.

Citations:

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Frequently Asked Questions

What does apigenin do?+

Apigenin is a plant flavone that works through two primary mechanisms relevant to longevity: (1) it inhibits CD38, the enzyme responsible for the majority of NAD+ destruction in aged tissue; (2) it modulates GABA-A receptors to support sleep onset. It also suppresses NF-κB, reducing inflammatory gene expression and senescent cell SASP.

Does apigenin really raise NAD+ levels?+

Apigenin does not add NAD+ directly – it protects NAD+ from being destroyed. By inhibiting CD38, it reduces the primary enzymatic degradation of NAD+ that accelerates with age. The evidence comes from the Escande/Chini 2013 mouse study showing higher liver NAD+ levels after apigenin treatment, and CD38 knockout studies showing sustained youthful NAD+ into old age.

Is chamomile tea the same as taking apigenin?+

Chamomile is the best dietary source (~1–2% apigenin by weight), but a cup of tea provides only 0.5–4 mg. Reaching 50 mg from chamomile alone would require 12–100 cups per day. Supplemental apigenin in the aglycone form (already deglycosylated) also absorbs more efficiently than the glycoside form in food.

Why is apigenin taken in the evening?+

Evening dosing allows apigenin's GABA-A modulation to support sleep onset at the time it is most useful. The CD38 inhibition benefit is not time-sensitive, but sleep support clearly is. An evening protocol makes the most of both mechanisms.

How does apigenin interact with NMN supplementation?+

Apigenin and NMN work on opposite sides of the NAD+ equation: NMN provides the precursor to build NAD+; apigenin inhibits CD38, which destroys NAD+ and intercepts NMN in transit. The combination is mechanistically synergistic – the studies on each individually suggest their effects should compound.

The Bottom Line: Apigenin is a rare compound that addresses two longevity pillars simultaneously -- protecting NAD+ from CD38 destruction during the day and supporting restorative sleep via GABA-A modulation at night.

Related Reading

Back to blog

Not sure which compounds to prioritize?

Take the 60-second quiz to get personalized recommendations based on your goals.

Take the Quiz →

Or just stay in the loop — no spam.

Keep reading

View all